Vor Biopharma Inc.
VOR
$2.17
-$0.03-1.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M |
| Total Depreciation and Amortization | 2.04M | 825.00K | 865.00K | 851.00K | 869.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.53B | 3.23M | 2.97M | 3.52M | 3.72M |
| Change in Net Operating Assets | 4.63M | -2.64M | 2.82M | -99.00K | 1.41M |
| Cash from Operations | -35.18M | -31.07M | -24.06M | -23.29M | -21.85M |
| Capital Expenditure | -152.00K | -231.00K | -72.00K | -34.00K | -9.00K |
| Sale of Property, Plant, and Equipment | 799.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00K | 1.00K | 0.00 | 0.00 | 53.00M |
| Cash from Investing | 646.00K | -230.00K | -72.00K | -34.00K | 52.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 97.00K | -- | 55.64M | 111.00K | 20.00K |
| Repurchase of Common Stock | -32.00K | -55.00K | -30.00K | -70.00K | -51.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 175.00M | -551.00K | -2.33M | -- | -- |
| Cash from Financing | 175.07M | -606.00K | 53.29M | 41.00K | -31.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.53M | -31.90M | 29.15M | -23.28M | 31.11M |